Virax Biolabs Group Limited
VRAX
NASDAQ3.88
USD
-0.01
- -
Total Valuation
Virax Biolabs Group Limited carries a market capitalization of 724,105.00, placing it among publicly traded companies globally.
| Market Cap | 724,105.00 |
| Enterprise Value | N/A |
Stock Price Statistics
Virax Biolabs Group Limited's stock has declined approximately -86.01802% over the past 52 weeks. The 50-day moving average sits at 4.44, while the 200-day moving average is 7.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | -86.01802% |
| 50-Day Moving Average | 4.44 |
| 200-Day Moving Average | 7.50 |
| Average Volume (20 Days) | N/A |
Stock Splits
Virax Biolabs Group Limited's most recent stock split took place on June 26, 2026 with a 25:1 split ratio.
| Last Split Date | 6/26/2026 |
| Split Ratio | 25:1 |